Literature DB >> 6087969

The 80th year of fifth disease.

P P Mortimer.   

Abstract

Mesh:

Year:  1984        PMID: 6087969      PMCID: PMC1442345          DOI: 10.1136/bmj.289.6441.338

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  10 in total

1.  Human parvovirus infections in France.

Authors:  A M Courouce; F Ferchal; F Morinet; A Muller; J Drouet; J P Soulier; Y Perol
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

2.  Nakatani antigen and human parvovirus (B19)

Authors:  K Okochi; R Mori; M Miyazaki; B J Cohen; P P Mortimer
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

3.  Human parvovirus, the cause of erythema infectiosum (fifth disease)?

Authors:  M J Anderson; S E Jones; S P Fisher-Hoch; E Lewis; S M Hall; C L Bartlett; B J Cohen; P P Mortimer; M S Pereira
Journal:  Lancet       Date:  1983-06-18       Impact factor: 79.321

4.  Parvovirus infections and hypoplastic crisis in sickle-cell anaemia.

Authors:  J R Pattison; S E Jones; J Hodgson; L R Davis; J M White; C E Stroud; L Murtaza
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

5.  Epidemic erythema infectiosum.

Authors:  E A Ager; T D Chin; J D Poland
Journal:  N Engl J Med       Date:  1966-12-15       Impact factor: 91.245

6.  Erythema infectiosum: an outbreak of "slapped cheek" disease in north Devon.

Authors:  H E Cramp; B D Armstrong
Journal:  Br Med J       Date:  1976-04-10

7.  Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent.

Authors:  G R Serjeant; J M Topley; K Mason; B E Serjeant; J R Pattison; S E Jones; R Mohamed
Journal:  Lancet       Date:  1981-09-19       Impact factor: 79.321

8.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

9.  A human parvovirus-like virus inhibits haematopoietic colony formation in vitro.

Authors:  P P Mortimer; R K Humphries; J G Moore; R H Purcell; N S Young
Journal:  Nature       Date:  1983 Mar 31-Apr 6       Impact factor: 49.962

10.  Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus.

Authors:  J Summers; S E Jones; M J Anderson
Journal:  J Gen Virol       Date:  1983-11       Impact factor: 3.891

  10 in total
  8 in total

1.  Hereditary spherocytosis in sisters unmasked by parvovirus infection.

Authors:  N J McLellan; N Rutter
Journal:  Postgrad Med J       Date:  1987-01       Impact factor: 2.401

2.  Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.

Authors:  Peter A C Maple; Lea Hedman; Pravesh Dhanilall; Kalle Kantola; Visa Nurmi; Maria Söderlund-Venermo; Kevin E Brown; Klaus Hedman
Journal:  J Clin Microbiol       Date:  2014-01-08       Impact factor: 5.948

3.  B19 parvovirus infection causing aplastic crisis in 3 out of 5 family members with hereditary spherocytosis.

Authors:  P T Murphy; J R O'Donnell
Journal:  Ir J Med Sci       Date:  1990-06       Impact factor: 1.568

4.  Parvovirus infection causing arthralgia.

Authors:  M T Everett
Journal:  J R Coll Gen Pract       Date:  1985-11

5.  Serologically proved intrauterine infection with parvovirus.

Authors:  P D Knott; G A Welply; M J Anderson
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-15

6.  Uncommon Haemophilus infections.

Authors:  R G Finch
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

7.  Erythema infectiosum in a village primary school: clinical and virological studies.

Authors:  J G Tuckerman; T Brown; B J Cohen
Journal:  J R Coll Gen Pract       Date:  1986-06

8.  The prevention of repeat-associated deletions in Saccharomyces cerevisiae by mismatch repair depends on size and origin of deletions.

Authors:  H T Tran; D A Gordenin; M A Resnick
Journal:  Genetics       Date:  1996-08       Impact factor: 4.562

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.